Clinical performance of anticardiolipin and antiβ2 glycoprotein i antibodies using a new automated chemiluminescent assay: Superior thrombotic prediction of combined results measured by two different methods

Blood Coagulation and Fibrinolysis

Volumn 25, Issue 1, 2014, Pages 10-15

  Chung, Yousun ^a   Kim, Ji Eun ^a   Lim, Hae S ^a   Kim, Hyun K ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

antibeta2 glycoprotein I antibody; anticardiolipin antibody; antiphospholipid syndrome; combined results; thrombotic risk

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOSTASIS TESTING SYSTEM; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PATIENT; PRIORITY JOURNAL; RISK FACTOR; THROMBOSIS;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; AUTOIMMUNE DISEASES; BETA 2-GLYCOPROTEIN I; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUMINESCENT MEASUREMENTS; MALE; THROMBOPHILIA; THROMBOSIS;

EID: 84893642816     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32836466b5     Document Type: Article

References (14)

1. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346:752-763.
2. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4:295-306.
3. Reber G, Boehlen F, de Moerloose P. Technical aspects in laboratory testing for antiphospholipid antibodies: is standardization an impossible dream? Semin Thromb Hemost 2008; 34:340- 346.
4. Galli M, Reber G, de Moerloose P, de Groot PG. Invitation to a debate on the serological criteria that define the antiphospholipid syndrome. J Thromb Haemost 2008; 6:399-401.
5. Dem P, Reber G, Musial J, Arnout J. Analytical and clinical performance of a new, automated assay panel for the diagnosis of antiphospholipid syndrome. J Thromb Haemost 2010; 8:1540- 1546.
6. Persijn L, Decavele AS, Schouwers S, Devreese K. Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and antibeta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome. Thromb Res 2011; 128:565- 569.
7. Capozzi A, Lococo E, Grasso M, Longo A, Garofalo T, Misasi R, Sorice M. Detection of antiphospholipid antibodies by automated chemiluminescence assay. J Immunol Methods 2012; 379: 48-52.
8. Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M, De Groot PG. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009; 7:1737-1740.
9. Tholen DW, Kaller A, Kennedy JW, Krouwer JS, Meier K. Evaluation of precision performancee of quantitative measurement methods; Approved guideline-second edition. CLSI 2004; 24:24-52.
10. Wong RC, Gillis D, Adelstein S, Baumgart K, Favaloro EJ, Hendle MJ, et al. Consensus guidelines on anticardiolipin antibody testing and reporting. Pathology 2004; 36:63-68.
11. Tripodi A. More on: criteria to define the antiphospholipid syndrome. J Thromb Haemost 2008; 6:1049-1050.
12. Pierangeli SS, Harris EN. A protocol for determination of anticardiolipin antibodies by ELISA. Nat Protoc 2008; 3:840-848.
13. Devreese KM. Antiphospholipid antibodies: evaluation of the thrombotic risk. Thromb Res 2012; 130 (SUPPL.1):S37-S40.
14. Pengo V, Ruffatti A, Legnani C, Gresele P, Barcellona D, Erba N, et al. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J Thromb Haemost 2010; 8:237-242.